BlackRock Discloses Significant Passive Stake in RxSight Inc.
Ticker: RXST · Form: SC 13G · Filed: Jan 29, 2024 · CIK: 1111485
| Field | Detail |
|---|---|
| Company | Rxsight, Inc. (RXST) |
| Form Type | SC 13G |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: institutional-ownership, passive-investment, SC-13G
TL;DR
**BlackRock just revealed a big, passive stake in RxSight, signaling institutional confidence.**
AI Summary
BlackRock Inc., a major investment firm, reported on January 29, 2024, that as of December 31, 2023, it holds a significant stake in RxSight, Inc. (NASDAQ: RXST). This filing indicates BlackRock's passive ownership of RxSight's Common Stock, signaling their belief in the company's long-term prospects. For current or prospective RxSight shareholders, this means a large, influential institutional investor sees value in the company, which can provide a level of stability and confidence in the stock.
Why It Matters
This filing shows a major institutional investor, BlackRock, has a substantial, passive stake in RxSight, which can be a vote of confidence for other investors.
Risk Assessment
Risk Level: low — A passive institutional stake generally indicates long-term investment intent rather than short-term trading, reducing immediate volatility risk.
Analyst Insight
An investor might view BlackRock's passive stake as a positive signal, suggesting long-term value in RxSight, and could consider further research into RxSight's fundamentals.
Key Players & Entities
- BlackRock Inc. (company) — the investment firm filing the SC 13G
- RxSight, Inc. (company) — the subject company whose shares are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 29, 2024 (date) — the filing date of the SC 13G
Forward-Looking Statements
- BlackRock will maintain a passive investment in RxSight, Inc. for the foreseeable future. (BlackRock Inc.) — high confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G filing, specifically filed under Rule 13d-1(b) as indicated by the '[X] Rule 13d-1(b)' checkbox.
Which company is the subject of this filing?
The subject company of this filing is RxSight, Inc., with CIK 0001111485 and business address 100 Columbia Street, Suite 120, Aliso Viejo, CA 92656.
Who is the entity making this filing?
The entity making this filing is BlackRock Inc., with CIK 0001364742 and business address 50 Hudson Yards, New York, NY 10001.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of RxSight, Inc. is 78349D107.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on January 29, 2024 regarding RxSight, Inc. (RXST).